ID   HL-60-Y3
AC   CVCL_WW75
DR   cancercelllines; CVCL_WW75
DR   Wikidata; Q94211534
RX   PubMed=8343448;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=8343448).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
RX   PubMed=8343448;
RA   Kajigaya, Yasuhiko
RA   Sasaki, Hideki
RA   Ikuta, Koichiro
RA   Matsuyama, Shusuke
RA   Hirabayashi, Yoko
RA   Inoue, Tohru
RT   "Serum-free culture for leukemia cells.";
RL   Hum. Cell 6:49-56(1993).
//